A nine-week-old girl presented to the emergency department with a 12 h history of fever and a 1 min generalized tonic-clonic seizure. Review of systems was otherwise negative. Her two-year-old sister experienced a fever and oropharyngeal ulcers two weeks before. On physical examination, she was febrile to 39.2°C rectal, but with otherwise normal vital signs. She was well-appearing and her examination was normal, including the neurological examination. Blood, urine and cerebrospinal fluid (CSF) specimens were obtained, and intravenous ceftriaxone, vancomycin and acyclovir were started.
DIAGNOSIS
Both the CSF and blood samples obtained on hospital day 3 returned positive results for HSV-1 using PCR, confirming a diagnosis of HSV encephalitis. Extracted DNA from the initial CSF was re-tested using a different laboratory-developed HSV 1 and HSV 2 quantitative realtime PCR assay at another reference laboratory. In retrospect, the initial CSF specimen was positive for HSV 1 (2,675 copies/mL) using this assay, as were the second CSF specimen (21,905 copies/mL) and the blood sample (12,089 copies/mL).
DISCUSSION
The present case emphasizes some of the challenges faced by clinicians in making an early diagnosis of HSV encephalitis in children. Compared with tissue culture from brain biopsy, PCR testing of the CSF has an estimated sensitivity of 98%, making it the diagnostic modality of choice (1) . However, several studies have demonstrated that the frequency of false-negative PCR results may be as high as 35% in children, especially during the first 72 h of illness (2) (3) (4) (5) . This is likely explained by the lower quantity of HSV DNA in the CSF at the onset of encephalitis (2) (3) (4) (5) . Using a quantitative HSV PCR assay, we observed a 10-fold increase in HSV DNA in our patient's CSF after 72 h on acyclovir. This highlights how HSV CSF titres may abruptly rise in the early stages of the disease and that the first week of antiviral therapy does not significantly reduce HSV PCR sensitivity (1) . Therefore, repeating a lumbar puncture if clinical suspicion persists is paramount (2) (3) (4) (5) . Moreover, CSF pleocytosis and
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This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http:// creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes. For commercial reuse, contact reprints@pulsus.com proteinosis, although classically associated with HSV encephalitis, may be absent initially, especially in CSF samples with low levels of HSV DNA (3, 6) . This further underscores the value of repeating CSF analyses when HSV encephalitis is suspected. In addition to the timing of CSF sampling, other factors may influence the ability to make a microbiological diagnosis of HSV encephalitis, such as interlaboratory variability in HSV PCR sensitivities. This may be due to differences in nucleic acid extraction efficiency, laboratory proficiency or the analytical sensitivity (ie, lower limit of detection) of the assay. In the present case, despite a reported lower limit of detection of <10 genome equivalents per analysis (7) and no known breaches in laboratory protocol application, the first assay failed to detect HSV in our patient's initial CSF sample.
The prognostic utility of the initial level of CSF HSV DNA remains unclear. Domingues et al (8) described the use of a quantitative CSF HSV PCR in 16 adult and pediatric patients with HSV encephalitis, and found that those with >100 copies of HSV DNA per microlitre, before or within four days of initiation of treatment, were more likely to display lesions on a computed tomography scan of the brain and poorer neurological outcomes. Conversely, other adult studies of HSV encephalitis have not observed this association.
In cases with low/undetectable CSF HSV viral load, blood HSV PCR may serve as a useful adjunct to make an early presumptive diagnosis of HSV encephalitis, particularly in patients with a primary infection. This is possible because the pathogenesis of HSV encephalitis in neonates and young infants includes primary infection with viremia and subsequent neuroinvasion (2) . In a retrospective cohort study involving 37 neonates with HSV disease, Kimura et al (9) detected HSV DNA in the blood of 73% of patients with a central nervous system infection. They also found that newborns with disseminated disease had a higher serum viral load than those with central nervous system infections (10 5.9±0.6 copies/mL versus 10 1.5±0.8 copies/mL, respectively) (9). Moreover, death and neurological sequelae among survivors were significantly associated with higher serum HSV DNA copy numbers (9) . Therefore, quantitative blood HSV PCR may also show promise as a prognostic tool in neonatal HSV disease.
Nevertheless, there is little information available regarding the added value of blood HSV PCR in cases of suspected encephalitis outside of the neonatal period, in which viremia is presumed to be less common. In a case series involving 24 non-neonatal pediatric HSV infections associated with a positive blood HSV PCR, Cantey et al (10) detected HSV viremia in two immunocompetent adolescents with HSV-1 encephalitis secondary to viral reactivation, a mechanism more frequently implicated in older children (2) .
Importantly, we do not recommend that a positive blood result be taken as confirmation that HSV is the causative agent of encephalitis, but rather that it be interpreted conjointly with clinical, imaging, electroencephalographic and CSF findings. Similarly, because the negative predictive value of blood HSV PCR in children outside the neonatal period is not known, a negative test should not lead to stopping empirical antiviral therapy when there is ongoing clinical suspicion for HSV encephalitis. Nevertheless, CSF HSV PCR remains the preferred diagnostic modality (1), and repeating a lumbar puncture is crucial if the initial test is negative and HSV remains a possibility.
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